AAS
TECH icon

Avantax Advisory Services’s Bio-Techne TECH Stock Holding History

Avantax Advisory Services’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$672K Sell
13,056
-796
-6% -$40K ﹤0.01% 1407
2025
Q1 		$812K Buy
13,852
+3,231
+30% +$219K ﹤0.01% 1196
2024
Q4 		$765K Sell
10,621
-1,934
-15% -$142K ﹤0.01% 1184
2024
Q3 		$1M Sell
12,555
-159
-1% -$11.9K 0.01% 1018
2024
Q2 		$911K Buy
+12,714
New +$936K 0.01% 1031

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Avantax Advisory Services's TECH Position: Q2 2025 in Review

Avantax Advisory Services reduced its Bio-Techne (TECH) stake by 5.7% in Q2 2025, selling an estimated $40K and leaving 13,056 shares worth $672K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Avantax Advisory Services first reported a position in TECH in Q2 2024 and has held it in 5 quarters since. The position peaked at $1M in Q3 2024. 555 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

  • Avantax Advisory Services held 13,056 shares of Bio-Techne worth $672K as of Q2 2025.
  • Avantax Advisory Services sold 796 Bio-Techne shares in Q2 2025, an estimated $40K.
  • Bio-Techne made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1407 holding.
  • Avantax Advisory Services first reported a position in Bio-Techne in Q2 2024 and has held it in 5 quarters since.
  • Avantax Advisory Services's Bio-Techne position peaked at $1M in Q3 2024.
  • 555 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.